Hatem Abou-Sayed
Fondatore presso ELEVAI LABS INC.
Patrimonio netto: 905 457 $ in data 31/05/2024
Profilo
Hatem Abou-Sayed is the founder of Elevai Labs, Inc. founded in 2020, where he holds the title of Director & Chief Medical Officer.
He is currently a Director at Fruit Street Health, P.B.C.
and a Managing Member at Zamzam Skin, LLC since 2017.
Dr. Abou-Sayed was a Vice-President at Interpreta, Inc. from 2015 to 2017.
He holds an MBA from Northwestern University, an undergraduate degree from the University of California, Berkeley, and a doctorate from the University of California Irvine School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ELEVAI LABS INC.
7.26% | 25/03/2024 | 1 371 905 ( 7.26% ) | 905 457 $ | 31/05/2024 |
Posizioni attive di Hatem Abou-Sayed
| Società | Posizione | Inizio |
|---|---|---|
| ELEVAI LABS INC. | Fondatore | 01/01/2020 |
Fruit Street Health, P.B.C.
 Fruit Street Health, P.B.C. Internet Software/ServicesTechnology Services Fruit Street Health, Inc. develops software applications for the healthcare professionals. It offers digital health and telemedicine to deliver the Center for Disease Control & Prevention’s (CDC’s) National Diabetes Prevention Program (DPP). It helps to prevent and treat lifestyle related disease using telemedicine, connected devices and mobile applications. The company was founded by Laurence Girard in 2014 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Hatem Abou-Sayed
| Società | Posizione | Fine |
|---|---|---|
Interpreta, Inc.
 Interpreta, Inc. Internet Software/ServicesTechnology Services Part of Centene Corp., Interpreta, Inc. is a healthcare analytics company that continuously updates, interprets, and synchronizes clinical data to create personalized roadmaps for timely care. The company is based in San Diego, CA. The company's real-time insights provide guidance to physicians, care managers, and health plans for quality improvement, clinical prioritization, population management, and precision medicine. The company was founded by Ahmed F. Ghouri, who has been the CEO since incorporation. Interpreta was acquired by Centene Corp. on March 27, 2018 for $175.92 million. | Corporate Officer/Principal | 01/01/2017 |
Formazione di Hatem Abou-Sayed
| Northwestern University | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
| University of California Irvine School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELEVAI LABS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Fruit Street Health, P.B.C.
Fruit Street Health, P.B.C. Internet Software/ServicesTechnology Services Fruit Street Health, Inc. develops software applications for the healthcare professionals. It offers digital health and telemedicine to deliver the Center for Disease Control & Prevention’s (CDC’s) National Diabetes Prevention Program (DPP). It helps to prevent and treat lifestyle related disease using telemedicine, connected devices and mobile applications. The company was founded by Laurence Girard in 2014 and is headquartered in New York, NY. | Technology Services |
Interpreta, Inc.
Interpreta, Inc. Internet Software/ServicesTechnology Services Part of Centene Corp., Interpreta, Inc. is a healthcare analytics company that continuously updates, interprets, and synchronizes clinical data to create personalized roadmaps for timely care. The company is based in San Diego, CA. The company's real-time insights provide guidance to physicians, care managers, and health plans for quality improvement, clinical prioritization, population management, and precision medicine. The company was founded by Ahmed F. Ghouri, who has been the CEO since incorporation. Interpreta was acquired by Centene Corp. on March 27, 2018 for $175.92 million. | Technology Services |
- Borsa valori
- Insiders
- Hatem Abou-Sayed
